WallStreetZenWallStreetZen

NASDAQ: ATHA
Athira Pharma Inc Stock Ownership - Who owns Athira Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Athira Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kevin ChurchCHIEF SCIENTIFIC OFFICER2025-07-018,526$0.29
$2.50kSell
Mark WorthingtonGeneral Counsel and CCO2025-07-018,526$0.29
$2.50kSell
Robert RenningerSVP Finance and Accounting2025-07-012,897$0.29
$848.82Sell
Mark James LittonPresident and CEO2025-07-0125,123$0.29
$7.36kSell
Martin Javier SanCHIEF MEDICAL OFFICER2025-07-0110,842$0.29
$3.18kSell
Kevin ChurchCHIEF SCIENTIFIC OFFICER2025-05-1910,000$0.23
$2.31kBuy
Robert RenningerSVP Finance and Accounting2025-05-1910,000$0.23
$2.31kBuy
Robert RenningerVP of Finance2025-01-022,881$0.56
$1.62kSell
Kevin ChurchCHIEF SCIENTIFIC OFFICER2025-01-028,510$0.56
$4.78kSell
Mark WorthingtonGeneral Counsel and CCO2025-01-028,510$0.56
$4.78kSell

1 of 2

ATHA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATHA insiders and whales buy or sell their stock.

ATHA Shareholders

What type of owners hold Athira Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC13.84%5,402,964$2.17MInsider
Perceptive Advisors LLC13.84%5,402,964$2.17MInstitution
Bml Capital Management LLC8.27%3,230,667$1.30MInstitution
Joseph Edelman7.98%3,114,805$1.25MInsider
Rtw Investments LP6.84%2,668,913$1.07MInsider
Vanguard Group Inc3.94%1,537,914$616.70kInstitution
Propel Bio Management LLC3.82%1,492,792$598.61kInstitution
Simplify Asset Management Inc3.82%1,492,792$598.61kInstitution
Tang Capital Management LLC1.54%600,000$240.60kInstitution
Bank Of America Corp1.07%416,203$166.90kInstitution

1 of 3

ATHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATHA44.84%32.35%Net SellingNet Selling
ADAP6.14%93.86%Net SellingNet Selling
EDSA18.82%81.18%Net Buying
NERV5.53%94.47%
MTVA0.81%99.19%Net BuyingNet Buying
View Top Biotech Stocks

Athira Pharma Stock Ownership FAQ

Who owns Athira Pharma?

Athira Pharma (NASDAQ: ATHA) is owned by 44.84% institutional shareholders, 32.35% Athira Pharma insiders, and 22.81% retail investors. Perceptive Advisors LLC is the largest individual Athira Pharma shareholder, owning 5.40M shares representing 13.84% of the company. Perceptive Advisors LLC's Athira Pharma shares are currently valued at $2.17M.

If you're new to stock investing, here's how to buy Athira Pharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.